Please use this identifier to cite or link to this item: http://repository.li.mahidol.ac.th/dspace/handle/123456789/16571
Title: The clinical benefit of adjunctive dexamethasone in tuberculous meningitis is not associated with measurable attenuation of peripheral or local immune responses
Authors: Cameron P. Simmons
Guy E. Thwaites
Nguyen Than Ha Quyen
Tran Thi Hong Chau
Pham Phuong Mai
Nguyen Thi Dung
Kasia Stepniewska
Nicholas J. White
Tran Tinh Hien
Jeremy Farrar
UCL
Mahidol University
Keywords: Immunology and Microbiology
Issue Date: 1-Jul-2005
Citation: Journal of Immunology. Vol.175, No.1 (2005), 579-590
Abstract: Outcome from tuberculous meningitis (TBM) is believed to be dependent on the severity of the intracerebral inflammatory response. We have recently shown that dexamethasone improved survival in adults with TBM and postulated that the clinical effect would be associated with a measurable systemic and intracerebral impact on immunological markers of inflammation. Prolonged inflammatory responses were detected in all TBM patients irrespective of treatment assignment (placebo or dexamethasone). The inflammatory response in the cerebrospinal fluid was characterized by a leukocytosis (predominantly CD3+CD4+T lymphocytes, phenotypically distinct from those in the peripheral blood), elevated concentrations of inflammatory and anti-inflammatory cytokines, chemokines, and evidence of prolonged blood-brain barrier dysfunction. Dexamethasone significantly modulated acute cerebrospinal fluid protein concentrations and marginally reduced IFN-γ concentrations; other immunological and routine biochemical indices of inflammation were unaffected. Peripheral blood monocyte and T cell responses to Mycobacterium tuberculosis Ags were also unaffected. Dexamethasone does not appear to improve survival from TBM by attenuating immunological mediators of inflammation in the subarachnoid space or by suppressing peripheral T cell responses to mycobacterial Ags. These findings challenge previously held theories of corticosteroid action in this disease. An understanding of how dexamethasone acts in TBM may suggest novel and more effective treatment strategies. Copyright © 2005 by The American Association of Immunologists, Inc.
URI: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=21244456366&origin=inward
http://repository.li.mahidol.ac.th/dspace/handle/123456789/16571
ISSN: 00221767
Appears in Collections:Scopus 2001-2005

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.